{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:29:03Z","timestamp":1765826943708},"reference-count":0,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BTT"],"DOI":"10.2147\/btt.s1956","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T02:47:22Z","timestamp":1281581242000},"page":"189","source":"Crossref","is-referenced-by-count":8,"title":["Natalizumab for the treatment of relapsing multiple sclerosis"],"prefix":"10.2147","author":[{"given":"Richard","family":"Rudick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2008,6]]},"container-title":["Biologics: Targets & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=2878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T21:57:12Z","timestamp":1477864632000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/natalizumab-for-the-treatment-of-relapsing-multiple-sclerosis-peer-reviewed-article-BTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/btt.s1956","relation":{},"ISSN":["1177-5475"],"issn-type":[{"value":"1177-5475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}